PB2697: LONG TERM PEJORATIVE IMPACT OF LENALIDOMIDE MAINTENANCE ON HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA. ANCILLARY STUDY OF THE PHASE III CLL6-RESIDUUM TRIAL

• Stephane Wasse,
• Tienhan Sandrine Dabakuyo-Yonli,
• Dan Engeler,
• David Gottlieb,
• Therese Aurran Schleinitz,
• Florence Cymbalista,
• Marc Maynadie

Affiliations

Stephane Wasse

1 Dijon-Bourgogne University Hospital, France

Tienhan Sandrine Dabakuyo-Yonli

2 Georges François Leclerc Comprehensive Cancer Centre, National Quality of Life and Cancer Clinical Research Platform, France

Dan Engeler

3 Australian Leukaemia and Lymphoma Group

David Gottlieb

4 Australian Leukaemia and Lymphoma Group

Therese Aurran Schleinitz

5 Institut Paoli Calmettes, France

Florence Cymbalista

6 Hôpital universitaire Avicenne, France

Marc Maynadie

7 Dijon-Bourgogne University Hospital, Bourgogne Franche-Comté University, France